Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
May 2013, Vol 4 No 3
Toxicity of Bendamustine Therapy
By
Susanne Liewer, PharmD, BCOP
Emerging Therapies
Read More ›
Safety of Bendamustine in Treatment of CLL and NHL
By
Colleen Ross, RN, MSN, MHA, OCN
Leukemia
Read More ›
Safety of Bendamustine in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
By
Julie M. Vose, MD, MBA
Leukemia
Read More ›
Safety of Bendamustine in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
By
Sebastian Stintzing, MD
Leukemia
Read More ›